FDA moves to fast-track review of psilocybin and methylone for mental health

Some psychedelic drugs, once considered fringe, are now getting a step closer to possibly being approved for use as mental ...
Monthly Prescribing Reference

FDA Grants Fast Track Status to BNT113 for HPV16+ Head and Neck Cancer

The FDA's Fast Track designation helps to accelerate the development and review of products for serious and life-threatening conditions. The Food and Drug Administration (FDA) has granted Fast Track ...
Cure Today

FDA Gives Fast Track Designation to Stenoparib in Advanced Ovarian Cancer

Stenoparib, targeting PARP1/2 and tankyrase 1/2, offers a unique mechanism for treating advanced ovarian cancer. The FDA's fast track designation facilitates expedited development and review, with ...
JD Supra

France Introduces a “Fast-Track” Scheme for the Authorisation of Certain Clinical Trials

France will introduce in 2026 a “fast-track” pathway aimed at accelerating the authorisation of certain mono-national clinical trials. Reserved in particular for early-phase studies, serious diseases ...
Healthline

Trump Administration Aims to Fast-Track Psychedelic Therapies for PTSD

President Trump issued an executive order to fast-track psychedelic therapies like ibogaine to treat PTSD and other mental ...